The combination of skincare and biotechnology leads to the latest developments and groundbreaking innovations.
AROCELL™ effectively treats and activates skin cells to help you restore and maintain your naturally radiant appearance.
Originally, Botulinum toxin was known exclusively for injections under various brand names.
Korean researchers have now successfully advanced Botulinum toxin into a novel, globally patented molecule, creating a new paradigm in Botulinum toxin system cosmetics.
AROCELL™
Innovative AROCELL™ Products with Botulinum Toxin
AROCELL™ The Injection-Free Botulinum System Cosmetics
In biotechnological research on skin aging, muscle contractions, mimic wrinkles, and nerve changes, Korean researchers at Seoul University have succeeded in isolating a novel Botulinum toxin A peptide. This peptide is delivered transdermally without injections into the deeper skin layers, where it naturally relaxes mimic muscles, contributing to long-lasting skin rejuvenation.
Previously, Botulinum toxin A applications were restricted to medical professionals, as treatment errors could lead to severe side effects and difficult-to-correct muscle paralysis.
Through a global patent, a specific peptide derived from Botulinum toxin A was coupled with a membrane protein, rendering it non-toxic to nerves while retaining its relaxing effect on mimic muscles. This peptide (Methionyl-r-Clostridium Botulinum Polypeptide-1 Hexapeptide-40) is formulated in a unique way to penetrate deep into the skin, relax wrinkle-causing muscles, and inhibit nerve activity. These nerves not only influence muscle activity but also alleviate migraines and facial pain.
Scientific Information
At Landsberg, customers enjoy the rare and increasingly lost feeling of trust in statements!
The effectiveness of AROCELL™ is proven and works. But read our scientific information for yourself.
The History of Botulinum Toxin
The German physician Dr. Justinus Christian Kerner (1786 *-1862 †) first described the physiological effects of botulinum toxin-induced illness in 1817, which caused many deaths due to paralysis of the respiratory or cardiac muscles.
Although the botulism pathogen was isolated only in 1897, Dr. Kerner recognized the therapeutic potential of the neurotoxin early on and envisioned its use for treating muscle tone disorders. It took 150 years for the substance to become fully applicable.
Botulinum Toxin
Here you can see pure Botulinum Toxin Type A at a molecular size with a molecular weight of 150 KDa (kilodaltons). This molecule is exclusively suitable for injection and should only be administered by experienced physicians.
Red = Light Chain A (Pure Toxin)
Blue = Heavy Chain
Interwoven in Hemagglutinin (Non-Toxin)
Needle-Free Botulinum Toxin
Here you can see pure Botulinum Toxin Type A at a molecular size with a molecular weight of 50 KDa (kilodaltons) docked onto a macromolecular transmission domain (MTD = macromolecule transmission domain). This innovative molecule penetrates the epidermal membrane needle-free in the form of a novel cream formulation.
Red = Light Chain A (Pure Toxin)
The image shows a structural model of needle-free Botulinum Toxin. It is a combination of pure botulinum toxin and a highly skin-compatible protein. The botulinum bacteria that secrete botulinum toxin are very dangerous. Therefore, we have isolated only the gene from botulinum bacteria that produces pure botulinum. It can be expressed in E. coli to make it safe and pure.
AROCELL™ is the only product featuring the new, globally patented botulinum toxin molecule with the precise designation:
“Methionyl r-Clostridium Botulinum Polypeptide-1 Hexapeptide-40”
Transdermal Delivery
Innovative AROCELL™ Products
AROCELL™ Europe Official in Social Media
AROCELL™ Distribution
Would you like to feature AROCELL™ products in your 5-star hotel, medical practice, or First-Class institute? We look forward to your distribution inquiry!